Claire Dibben
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Claire Dibben has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
A. I. Adler
1 shared publication- Andrew F. Tarbuck
Badrakalimuthu, Beechcroft, Fulbourn Hospital, Cambridge CB21 5EF, UK
1 shared publication - Christopher O'Loughlin
Cambridgeshire & Peterborough NHS Fdn Trust, Cambridge, England
1 shared publication Deborah Girling
Older People's Mental Health Services, Box 311, Fulbourn Hospital, Cambridge CB1 5EF, UK
1 shared publicationF. A. Hynes
1 shared publication- Golam Khandaker1 shared publication
Latest Publications
- 1 May 2009
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 39 (9) , 1577
Essential Psychiatry, Fourth Edition. Edited by R. M. Murray, K. S. Kendler, P. McGuffin, S. Wessely and D. J. Castle. (Pp. 735, £48.00, ISBN 978-0-521-60408-6.) Cambridge University Press: Cambridge, UK. 2008.
- 1 May 2009
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 39 (9) , 1577
Essential Psychiatry, Fourth Edition. Edited by R. M. Murray, K. S. Kendler, P. McGuffin, S. Wessely and D. J. Castle. (Pp. 735, £48.00, ISBN 978-0-521-60408-6.) Cambridge University Press: Cambridge, UK. 2008.
- 14 September 2006
- Published by Elsevier in General Hospital Psychiatry
- Vol. 28 (5) , 437-439
A survey of psychiatric liaison services for older adults in the eastern region of the United Kingdom
- 14 September 2006
- Published by Elsevier in General Hospital Psychiatry
- Vol. 28 (5) , 437-439
A survey of psychiatric liaison services for older adults in the eastern region of the United Kingdom
- 1 September 2005
- Published by SAGE Publications in The International Journal of Psychiatry in Medicine
- Vol. 35 (3) , 307-311
Diabetes Associated with Atypical Antipsychotic Treatment May Be Severe but Reversible: Case Report
Objective: To draw attention to severe presentations of atypical neuroleptic related diabetes and to document that a marked degree of remission can take place after drug withdrawal. Method: We describe two patients who presented with diabetic ketoacidosis after treatment with quetiapine and risperidone, respectively. Results: Both patients were negative for islet cell antibodies. They both required treatment with insulin, one in very high dosage, but their insulin requirements fell progressively after the atypical antipsychotic was withdrawn. After several months, neither patient required antidiabetic treatment. Conclusions: Atypical antipsychotic-induced diabetes does not always take a “type 2” presentation in which weight gain and insulin resistance are implicated. Sometimes the presentation is with diabetic ketoacidosis, requiring insulin treatment, which can nevertheless be reversible.
- 1 September 2005
- Published by SAGE Publications in The International Journal of Psychiatry in Medicine
- Vol. 35 (3) , 307-311
Diabetes Associated with Atypical Antipsychotic Treatment May Be Severe but Reversible: Case Report
Objective: To draw attention to severe presentations of atypical neuroleptic related diabetes and to document that a marked degree of remission can take place after drug withdrawal. Method: We describe two patients who presented with diabetic ketoacidosis after treatment with quetiapine and risperidone, respectively. Results: Both patients were negative for islet cell antibodies. They both required treatment with insulin, one in very high dosage, but their insulin requirements fell progressively after the atypical antipsychotic was withdrawn. After several months, neither patient required antidiabetic treatment. Conclusions: Atypical antipsychotic-induced diabetes does not always take a “type 2” presentation in which weight gain and insulin resistance are implicated. Sometimes the presentation is with diabetic ketoacidosis, requiring insulin treatment, which can nevertheless be reversible.
Motivating a team
Recent emphasis on clinical governance has made it increasingly important for managers to understand what motivates their team, in order to achieve the best results from them. It is said that performance = ability x motivation. Motivation can be defined as an internal drive to direct …
Motivating a team
Recent emphasis on clinical governance has made it increasingly important for managers to understand what motivates their team, in order to achieve the best results from them. It is said that performance = ability x motivation. Motivation can be defined as an internal drive to direct …